ライフサイエンスコーパス: cyanocobalamin

1 lcobalamins and the reductive decyanation of cyanocobalamin.

2 de, to transform all forms of cobalamin into cyanocobalamin.

3 tive decyanation reaction when it encounters cyanocobalamin.

4 , ferritin, from a small biological organic, cyanocobalamin.

5 ication of the corrin ring b-propionamide of cyanocobalamin.

6 respectively, than transcobalamin binding to cyanocobalamin.

7 ding capacity assay and compared to DTPA and cyanocobalamin.

8 the transcobalamin proteins when compared to cyanocobalamin.

9 ot the pdu) operon is repressed by exogenous cyanocobalamin.

10 In cobalamin deficiency, 2 mg of cyanocobalamin administered orally on a daily basis was

11 ystal structures of human HC in complex with cyanocobalamin and cobinamide at 2.35 and 3.0 A resoluti

12 consists of 1 mg of folic acid and 0.5 mg of cyanocobalamin and the diet that includes grains fortifi

13 protein required for high-affinity uptake of cyanocobalamin and the translocation of E group colicins

14 s performed for measurement of homocysteine, cyanocobalamin, and erythrocyte folate in participants o

15 ridoxine HCl; 50 microg each of d-biotin and cyanocobalamin; and 400 mcg of folate) or placebo for 30

16 g folic acid, 7.2 mg pyridoxine, and 0.02 mg cyanocobalamin), antioxidant vitamins alone (150 mg asco

17 osed cobalamin deficient patients to receive cyanocobalamin as either 1 mg intramuscularly on days 1,

18 Methyl-, adenosyl- and cyanocobalamin-b-(4-aminobutyl)-amide-DTPA analogs and D

19 Methyl-, adenosyl- and cyanocobalamin-b-(4-aminobutyl)-amide-DTPA analogs were

20 Cyanocobalamin-b-(5-aminopentylamide) was immobilized on

21 Transcobalamin binds cyanocobalamin-b-(5-aminopentylamide) with association a

22 Cyanocobalamin (B12) functions as the biocompatible wate

23 Response data for cyanocobalamin binding to the transcobalamin protein sur

24 Exogenously added transcobalamin II-[57Co]cyanocobalamin bound very poorly (2-5%) to the affected

25 cobalt containing compounds, namely Co(II), cyanocobalamin (CN-Cbl) and hydroxylcobalamin (OH-Cbl),

26 In the presence of calcium, cyanocobalamin (CN-Cbl) displaces E-peptide-1 with a nan

27 plicated calcium in high-affinity binding of cyanocobalamin (CN-Cbl) to BtuB.

28 showed that of the four Co(III) derivatives (cyanocobalamin [CN-Cbl], aquocobalamin [H2O-Cbl], adenos

29 ter-membrane transporter for vitamin B12 (or cyanocobalamin, CN-Cbl) in Escherichia coli.

30 racterize the photochemistry of vitamin B12, cyanocobalamin (CNCbl), in solution.

31 ependent reductive decyanation activity with cyanocobalamin (CNCbl).

32 B-dependent active transport of vitamin B12 [cyanocobalamin (CNCbl)] across the outer membrane of Esc

33 aimed to investigate the stability of added cyanocobalamin (CNCbl, chemically modified form) and hyd

34 e excited-state photophysics of vitamin B12 (cyanocobalamin, CNCbl) and the related cob(III)alamins,

35 acobalamin (H(2)OCbl(+)), and vitamin B(12) (cyanocobalamin, CNCbl).

36 o 1 of 3 dosage groups: 0, 25, or 100 microg cyanocobalamin/d.

37 ermination of 5'-hydroxy-alpha-ribofuranosyl cyanocobalamin derivatives with solely 1-D (13)C and DEP

38 of how the cyanide group in vitamin B(12) or cyanocobalamin, discovered 60 years ago, is removed, has

39 The structure of cyanocobalamin in DMSO-d(6) has been assigned using COSY

40 ive method for the detection of vitamin B12 (cyanocobalamin) is presented.

41 ut not decyanation activity, suggesting that cyanocobalamin might be therapeutically useful for patie

42 be rescued by the addition of vitamin B(12) (cyanocobalamin) or the lower ligand of cobalamin, 5,6-di

43 patients with known CHD with folic acid and cyanocobalamin over a 10-year period would result in 310

44 ctivities for processing alkylcobalamins and cyanocobalamin, respectively, to a common intermediate t

45 Folic acid and cyanocobalamin supplementation may be cost-effective amo

46 ve elevated serum MMA were treated with oral cyanocobalamin tablets (1000 microg/d) for 3 mo.

47 Unlike cyanocobalamin transport through the outer membrane, FeE

48 ity, catalyzing the reductive decyanation of cyanocobalamin (vitamin B(12)), and the dealkylation of

49 and its nutritional determinants folate and cyanocobalamin (vitamin B-12) have been shown to affect

50 Co could also be separated from Co bound to cyanocobalamin (vitamin B-12).

51 xine hydrochloride (vitamin B6), and 2 mg of cyanocobalamin (vitamin B12) or a placebo.

52 of new force-field parameters developed for cyanocobalamin, we also simulated the substrate-bound fo

53 mocysteine, red blood cell folate, and serum cyanocobalamin were unrelated to ARM in the overall samp

54 btuB RNA was inhibited by Ado-Cbl but not by cyanocobalamin, with half-maximal inhibition around 0.3